Drug-induced polyneuropathy. Drug-induced polyneuropathy
Conditions
Interventions
Intervention 1: Intervention group: Cancer patients treated with chemotherapy will be treated with duloxetine. Group A patient are treated with 30 mg of duloxetine capsules in the first week and then
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age over 18 years and under 80 years Cancer patients based on the diagnosis of the physician and the pathology sample Willingness and consent to participate in the study Do not use drugs that affect serotonin levels Do not use painkillers and drugs effective on neuropathic pain routinely from two weeks before starting duloxetine or venlafaxine
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the average BPI score in the group treated with duloxetine and venlafaxine and placebo. Timepoint: at the beginning of treatment, weeks 6 and 12. Method of measurement: brief pain inventory.;Comparison of mean SF36 score in the group treated with duloxetine and venlafaxine and placebo. Timepoint: at the beginning of treatment, weeks 6 and 12. Method of measurement: Item short form survey36. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNajmeh shahini
Gorgan University of Medical Sciences
Outcome results
None listed